Education
About Us
Working with TipRanks
Follow Us
Kenvue, Inc. (KVUE)
NYSE:KVUE
KVUE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$17.67 - $25.17
Previous CloseN/A
Volume2.33M
Average Volume (3M)18.90M
Market Cap
$41.01B
Enterprise Value$50.40B
Total Cash (Recent Filing)$1.06B
Total Debt (Recent Filing)$8.74B
Price to Earnings (P/E)38.9
Beta0.32
Next Earnings
Jul 17, 2025EPS Estimate
0.28Last Dividend Ex-Date
May 14, 2025Dividend Yield3.84%
Share Statistics
EPS (TTM)0.24
Shares Outstanding1,919,909,900
10 Day Avg. Volume19,800,422
30 Day Avg. Volume18,897,726
Financial Highlights & Ratios
PEG Ratio0.36
Price to Book (P/B)2.77
Price to Sales (P/S)0.00
P/FCF Ratio16.04
Enterprise Value/Market Cap1.23
Enterprise Value/Revenue0.82
Enterprise Value/Gross Profit5.68
Enterprise Value/Ebitda3.90
Forecast
1Y Price Target
$25.33Price Target Upside18.59% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Kenvue, Inc. News
Bulls Say, Bears Say
Bulls Say
Brand PerformanceTracked data shows early signs of recovery for key brands like Neutrogena and Aveeno, indicating management's initiatives might be starting to bear fruit.
Innovation And ExpansionKenvue's innovation engine continues with today's announcement of the globally-recognized Tylenol brand expanding into the supplement market.
US Market GrowthKenvue's US retail trends have recently flipped to growth.
Bears Say
Distribution And Market HeadwindsOngoing headwinds from China distribution challenges persist for KVUE.
Market ChallengesThe company faces several near-term challenges, including broader macro uncertainty and ongoing consumer pressure.
Portfolio ReshapingThe news of potential brand divestitures could be viewed as a disappointment for investors looking for greater portfolio reshaping actions.
Ownership Overview
1.12% Insiders
36.14% Mutual Funds
14.15% Other Institutional Investors
20.99% Public Companies and Individual Investors
KVUE FAQ
What was Kenvue, Inc.’s price range in the past 12 months?
Kenvue, Inc. lowest stock price was $17.67 and its highest was $25.17 in the past 12 months.
What is Kenvue, Inc.’s market cap?
Kenvue, Inc.’s market cap is $41.01B.
When is Kenvue, Inc.’s upcoming earnings report date?
Kenvue, Inc.’s upcoming earnings report date is Jul 17, 2025 which is in 25 days.
How were Kenvue, Inc.’s earnings last quarter?
Kenvue, Inc. released its earnings results on May 08, 2025. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.227 by $0.013.
Is Kenvue, Inc. overvalued?
According to Wall Street analysts Kenvue, Inc.’s price is currently Undervalued.
Does Kenvue, Inc. pay dividends?
Kenvue, Inc. pays a Quarterly dividend of $0.205 which represents an annual dividend yield of 3.84%. See more information on Kenvue, Inc. dividends here
What is Kenvue, Inc.’s EPS estimate?
Kenvue, Inc.’s EPS estimate is 0.28.
How many shares outstanding does Kenvue, Inc. have?
Kenvue, Inc. has 1,919,909,900 shares outstanding.
What happened to Kenvue, Inc.’s price movement after its last earnings report?
Kenvue, Inc. reported an EPS of $0.24 in its last earnings report, beating expectations of $0.227. Following the earnings report the stock price went up 4.103%.
Which hedge fund is a major shareholder of Kenvue, Inc.?
Currently, no hedge funds are holding shares in KVUE
Kenvue, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$25.33 (18.59% Upside)
$25.33 (18.59% Upside)
Blogger Sentiment
Bullish
KVUE Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 8.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $393.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 0.7%
Last 30 Days ▼ 0.7%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.80%
12-Months-Change
Fundamentals
Return on Equity
10.22%
Trailing 12-Months
Asset Growth
-3.76%
Trailing 12-Months
Company Description
Kenvue, Inc.
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
KVUE Company Deck
KVUE Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook for Kenvue, with strong execution of strategic plans and market share gains in certain segments overshadowed by organic sales declines and challenges in the Skin Health and Beauty segment. The impact of tariffs and foreign exchange rates also posed significant challenges.Read More>KVUE Revenue Breakdown
42.23% Self Care
30.33% Essential Health
27.43% Skin Health and Beauty
KVUE Stock 12 Month Forecast
Average Price Target
$25.33
▲(18.59%Upside)